Literature DB >> 15870282

Regulation of the small GTPase Rap1 and extracellular signal-regulated kinases by the costimulatory molecule CTLA-4.

Tara J Dillon1, Kendall D Carey, Scott A Wetzel, David C Parker, Philip J S Stork.   

Abstract

The mitogen-activated protein kinase extracellular signal-regulated kinase (ERK) is activated following engagement of the T-cell receptor and is required for interleukin 2 (IL-2) production and T-cell proliferation. This activation is enhanced by stimulation of the coreceptor CD28 and inhibited by the coreceptor CTLA-4. We show that the small G protein Rap1 is regulated in the opposite manner; it is inhibited by CD28 and activated by CTLA-4. Together, CD3 and CTLA-4 activate Rap1 in a sustained manner. To delineate T-cell function in the absence of Rap1 activity, we generated transgenic mice expressing Rap1GAP1, a Rap1-specific GTPase-activating protein. Transgenic mice showed lymphadenopathy, and transgenic T cells displayed increased ERK activation, proliferation, and IL-2 production. More significantly, the inhibitory effect of CTLA-4 on T-cell function in Rap1GAP1-transgenic T cells was reduced. We demonstrate that CTLA-4 activates Rap1, and we propose that intracellular signals from CTLA-4 antagonize CD28, at least in part, at the level of Rap1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15870282      PMCID: PMC1087740          DOI: 10.1128/MCB.25.10.4117-4128.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

1.  The GTPase-activating protein Rap1GAP uses a catalytic asparagine.

Authors:  Oliver Daumke; Michael Weyand; Partha P Chakrabarti; Ingrid R Vetter; Alfred Wittinghofer
Journal:  Nature       Date:  2004-05-13       Impact factor: 49.962

2.  Superantigen responses and co-stimulation: CD28 and CTLA-4 have opposing effects on T cell expansion in vitro and in vivo.

Authors:  M F Krummel; T J Sullivan; J P Allison
Journal:  Int Immunol       Date:  1996-04       Impact factor: 4.823

3.  CTLA-4 can function as a negative regulator of T cell activation.

Authors:  T L Walunas; D J Lenschow; C Y Bakker; P S Linsley; G J Freeman; J M Green; C B Thompson; J A Bluestone
Journal:  Immunity       Date:  1994-08       Impact factor: 31.745

4.  CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice.

Authors:  E A Tivol; S D Boyd; S McKeon; F Borriello; P Nickerson; T B Strom; A H Sharpe
Journal:  J Immunol       Date:  1997-06-01       Impact factor: 5.422

5.  CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells.

Authors:  M F Krummel; J P Allison
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

6.  An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells.

Authors:  Lalitha Vijayakrishnan; Jacqueline M Slavik; Zsolt Illés; Rebecca J Greenwald; Dan Rainbow; Bernhard Greve; Laurence B Peterson; David A Hafler; Gordon J Freeman; Arlene H Sharpe; Linda S Wicker; Vijay K Kuchroo
Journal:  Immunity       Date:  2004-05       Impact factor: 31.745

7.  MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells.

Authors:  C E Whitehurst; T D Geppert
Journal:  J Immunol       Date:  1996-02-01       Impact factor: 5.422

8.  Depolarization-induced tyrosine phosphorylation in PC12h cells.

Authors:  N Okumura; M Okada; H Nakagawa
Journal:  J Biochem       Date:  1994-08       Impact factor: 3.387

9.  Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.

Authors:  E A Tivol; F Borriello; A N Schweitzer; W P Lynch; J A Bluestone; A H Sharpe
Journal:  Immunity       Date:  1995-11       Impact factor: 31.745

10.  CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.

Authors:  M F Krummel; J P Allison
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

View more
  21 in total

1.  Extracellular calcium elicits feedforward regulation of the Toll-like receptor-triggered innate immune response.

Authors:  Songqing Tang; Taoyong Chen; Mingjin Yang; Lei Wang; Zhou Yu; Bin Xie; Cheng Qian; Sheng Xu; Nan Li; Xuetao Cao; Jianli Wang
Journal:  Cell Mol Immunol       Date:  2015-08-17       Impact factor: 11.530

2.  Regulatory T cells require TCR signaling for their suppressive function.

Authors:  Amanda M Schmidt; Wen Lu; Vishal J Sindhava; Yanping Huang; Janis K Burkhardt; Enjun Yang; Matthew J Riese; Jonathan S Maltzman; Martha S Jordan; Taku Kambayashi
Journal:  J Immunol       Date:  2015-03-27       Impact factor: 5.422

3.  Cytotoxic-T-lymphocyte antigen 4 receptor signaling for lymphocyte adhesion is mediated by C3G and Rap1.

Authors:  Yoel Kloog; Adam Mor
Journal:  Mol Cell Biol       Date:  2014-01-06       Impact factor: 4.272

4.  CTLA-4 up-regulation of lymphocyte function-associated antigen 1 adhesion and clustering as an alternate basis for coreceptor function.

Authors:  Helga Schneider; Elke Valk; Silvy da Rocha Dias; Bin Wei; Christopher E Rudd
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-26       Impact factor: 11.205

Review 5.  Multiple roles of Rap1 in hematopoietic cells: complementary versus antagonistic functions.

Authors:  Philip J S Stork; Tara J Dillon
Journal:  Blood       Date:  2005-08-02       Impact factor: 22.113

6.  Murine regulatory T cells differ from conventional T cells in resisting the CTLA-4 reversal of TCR stop-signal.

Authors:  Yuning Lu; Helga Schneider; Christopher E Rudd
Journal:  Blood       Date:  2012-10-09       Impact factor: 22.113

7.  B-Raf is required for positive selection and survival of DP cells, but not for negative selection of SP cells.

Authors:  Tara J Dillon; Maho Takahashi; Yanping Li; Srilatha Tavisala; Susan E Murray; Amy E Moran; David C Parker; Philip J S Stork
Journal:  Int Immunol       Date:  2013-01-18       Impact factor: 4.823

8.  Rap1b regulates B cell development, homing, and T cell-dependent humoral immunity.

Authors:  Haiyan Chu; Aradhana Awasthi; Gilbert C White; Magdalena Chrzanowska-Wodnicka; Subramaniam Malarkannan
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

9.  Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects.

Authors:  Maria Grazia Ruocco; Karsten A Pilones; Noriko Kawashima; Michael Cammer; Julie Huang; James S Babb; Mengling Liu; Silvia C Formenti; Michael L Dustin; Sandra Demaria
Journal:  J Clin Invest       Date:  2012-09-04       Impact factor: 14.808

Review 10.  Crosstalk between Mycobacterium tuberculosis and the host cell.

Authors:  Bappaditya Dey; William R Bishai
Journal:  Semin Immunol       Date:  2014-10-07       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.